Literature DB >> 30076572

Outpatient Complex Case Management: Health System-Tailored Risk Stratification Taxonomy to Identify High-Cost, High-Need Patients.

Eboni G Price-Haywood1,2, Hans Petersen3, Jeffrey Burton4, Jewel Harden-Barrios4, Mary Adubato4, Melissa Roberts5, Nathan Markward4.   

Abstract

BACKGROUND: U.S. health systems, incentivized by financial penalties, are designing programs such as case management to reduce service utilization among high-cost, high-need populations. The major challenge is identifying patients for whom targeted programs are most effective for achieving desired outcomes.
OBJECTIVE: To evaluate a health system's outpatient complex case management (OPCM) for Medicare beneficiaries for patients overall and for high-risk patients using system-tailored taxonomy, and examine whether OPCM lowers service utilization and healthcare costs.
DESIGN: Retrospective case-control study using Medicare data collected between 2012 and 2016 for Ochsner Health System. PARTICIPANTS: Super-utilizers defined as Medicare patients with at least two hospital/ED encounters within 180 days of the index date including the index event. INTERVENTION: Outpatient complex case management. MAIN MEASURES: Propensity score-adjusted multivariable logistic regression analysis was conducted for primary outcomes (90-day hospital readmission; 90-day ED re-visit). A difference-in-difference analysis was conducted to examine changes in per membership per month (PMPM) costs based on OPCM exposure. KEY
RESULTS: Among 18,882 patients, 1197 (6.3%) were identified as "high-risk" and 470 (2.5%) were OPCM participants with median enrollment of 49 days. High-risk OPCM cases compared to high-risk controls had lower odds of 90-day hospital readmissions (0.81 [0.40-1.61], non-significant) and lower odds of 90-day ED re-visits (0.50 [0.32-0.79]). Non-high-risk OPCM cases compared to non-high-risk controls had lower odds of 90-day hospital readmissions (0.20 [0.11-0.36]) and 90-day ED re-visits (0.66 [0.47-0.94]). Among OPCM cases, high-risk patients compared to non-high-risk patients had greater odds of 90-day hospital readmissions (4.44 [1.87-10.54]); however, there was no difference in 90-day ED re-visits (0.99 [0.58-1.68]). Overall, OPCM cases had lower total cost of care compared to controls (PMPM mean [SD]: - $1037.71 [188.18]).
CONCLUSIONS: Use of risk stratification taxonomy for super-utilizers can identify patients most likely to benefit from case management. Future studies must further examine which OPCM components drive improvements in select outcome for specific populations.

Entities:  

Keywords:  Medicare; case management; health services research; utilization

Mesh:

Year:  2018        PMID: 30076572      PMCID: PMC6206347          DOI: 10.1007/s11606-018-4616-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  18 in total

1.  Estimating treatment effects using observational data.

Authors:  Ralph B D'Agostino; Ralph B D'Agostino
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Executive function, episodic memory, and Medicare expenditures.

Authors:  Alex C Bender; Andrea M Austin; Francine Grodstein; Julie P W Bynum
Journal:  Alzheimers Dement       Date:  2017-02-04       Impact factor: 21.566

Review 4.  Successful models of comprehensive care for older adults with chronic conditions: evidence for the Institute of Medicine's "retooling for an aging America" report.

Authors:  Chad Boult; Ariel Frank Green; Lisa B Boult; James T Pacala; Claire Snyder; Bruce Leff
Journal:  J Am Geriatr Soc       Date:  2009-12       Impact factor: 5.562

5.  Healthcare costs associated with depression in medically Ill fee-for-service medicare participants.

Authors:  Jürgen Unützer; Michael Schoenbaum; Wayne J Katon; Ming-Yu Fan; Harold A Pincus; Diane Hogan; Jennifer Taylor
Journal:  J Am Geriatr Soc       Date:  2009-01-16       Impact factor: 5.562

6.  The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.

Authors:  Thanh G N Ton; Thomas DeLeire; Suepattra G May; Ningqi Hou; Mahlet G Tebeka; Er Chen; Joshua Chodosh
Journal:  Alzheimers Dement       Date:  2016-09-28       Impact factor: 21.566

7.  High-Need, High-Cost Patients: Who Are They and How Do They Use Health Care? A Population-Based Comparison of Demographics, Health Care Use, and Expenditures.

Authors:  Susan L Hayes; Claudia A Salzberg; Douglas McCarthy; David C Radley; Melinda K Abrams; Tanya Shah; Gerard F Anderson
Journal:  Issue Brief (Commonw Fund)       Date:  2016-08

8.  Effects of Cognition, Function, and Behavioral and Psychological Symptoms on Medicare Expenditures and Health Care Utilization for Persons With Dementia.

Authors:  Eric Jutkowitz; Robert L Kane; Bryan Dowd; Joseph E Gaugler; Richard F MacLehose; Karen M Kuntz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-06-01       Impact factor: 6.053

Review 9.  Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies.

Authors:  Markus C Elze; John Gregson; Usman Baber; Elizabeth Williamson; Samantha Sartori; Roxana Mehran; Melissa Nichols; Gregg W Stone; Stuart J Pocock
Journal:  J Am Coll Cardiol       Date:  2017-01-24       Impact factor: 24.094

Review 10.  Effectiveness of Case Management for 'At Risk' Patients in Primary Care: A Systematic Review and Meta-Analysis.

Authors:  Jonathan Stokes; Maria Panagioti; Rahul Alam; Kath Checkland; Sudeh Cheraghi-Sohi; Peter Bower
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

View more
  1 in total

1.  Impactability Modeling for Reducing Medicare Accountable Care Organization Payments and Hospital Events in High-Need High-Cost Patients: Longitudinal Cohort Study.

Authors:  Maureen A Smith; Menggang Yu; Jared D Huling; Xinyi Wang; Allie DeLonay; Jonathan Jaffery
Journal:  J Med Internet Res       Date:  2022-06-13       Impact factor: 7.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.